EI
AMGN icon

Ethic Inc’s Amgen AMGN Stock Holding History

Ethic Inc’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.3M Buy
56,184
+5,644
+11% +$1.93M 0.25% 59
2026
Q1 		$17.8M Buy
50,540
+4,468
+10% +$1.59M 0.28% 58
2025
Q4 		$15.1M Buy
46,072
+4,331
+10% +$1.37M 0.23% 72
2025
Q3 		$11.8M Buy
41,741
+1,301
+3% +$377K 0.19% 106
2025
Q2 		$11.2M Buy
40,440
+2,157
+6% +$611K 0.2% 102
2025
Q1 		$11.7M Sell
38,283
-11,547
-23% -$3.41M 0.24% 83
2024
Q4 		$13M Buy
49,830
+8,393
+20% +$2.49M 0.26% 62
2024
Q3 		$11.8M Sell
41,437
-2,022
-5% -$661K 0.3% 64
2024
Q2 		$13.6M Buy
43,459
+2,022
+5% +$594K 0.32% 59
2024
Q1 		$11.8M Sell
41,437
-274
-0.7% -$80.2K 0.3% 64
2023
Q4 		$12M Buy
41,711
+1,703
+4% +$464K 0.36% 48
2023
Q3 		$10.8M Buy
40,008
+9,924
+33% +$2.48M 0.38% 38
2023
Q2 		$6.68M Sell
30,084
-2,985
-9% -$693K 0.25% 85
2023
Q1 		$7.99M Buy
33,069
+9,109
+38% +$2.24M 0.32% 61
2022
Q4 		$6.29M Buy
23,960
+2,478
+12% +$664K 0.34% 60
2022
Q3 		$4.84M Sell
21,482
-2,934
-12% -$711K 0.33% 68
2022
Q2 		$5.94M Sell
24,416
-12,522
-34% -$3.07M 0.41% 41
2022
Q1 		$8.93M Buy
36,938
+8,848
+31% +$2.03M 0.62% 19
2021
Q4 		$6.32M Buy
28,090
+4,742
+20% +$1M 0.49% 36
2021
Q3 		$4.96M Buy
23,348
+3,359
+17% +$773K 0.51% 31
2021
Q2 		$4.87M Buy
19,989
+5,761
+40% +$1.42M 0.59% 28
2021
Q1 		$3.54M Buy
14,228
+4,524
+47% +$1.08M 0.63% 27
2020
Q4 		$2.23M Buy
9,704
+2,395
+33% +$552K 0.59% 27
2020
Q3 		$1.86M Buy
7,309
+2,098
+40% +$520K 0.71% 25
2020
Q2 		$1.23M Buy
5,211
+669
+15% +$153K 0.7% 33
2020
Q1 		$921K Buy
4,542
+431
+10% +$94.1K 0.77% 23
2019
Q4 		$991K Buy
+4,111
New +$906K 0.73% 27

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ethic Inc's AMGN Position: Q2 2026 in Review

Ethic Inc increased its Amgen (AMGN) stake by 11% in Q2 2026, buying an estimated $1.93M and bringing the position to 56,184 shares worth $20.3M. The position accounts for 0.25% of the portfolio, ranked #59.

Ethic Inc first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ethic Inc held 56,184 shares of Amgen worth $20.3M as of Q2 2026.
  • Ethic Inc bought 5,644 Amgen shares in Q2 2026, an estimated $1.93M.
  • Amgen made up 0.25% of Ethic Inc's portfolio in Q2 2026, its #59 holding.
  • Ethic Inc first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.